Search research articles
Contact Us
Filters
Showing results (411-420 of 480) with videos related to
Page
of 48
Sort By:
International Journal of Geriatric Psychiatry
|
September 28, 2022
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
Lancet (London, England)
|
September 25, 2025
Treatment for Alzheimer's disease
Nick C Fox, Christopher Belder, Clive Ballard, et al.
BMJ Open
|
March 1, 2022
PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trial
Jane L Cross, Simon P Hammond, Lee Shepstone, et al.
Brain Pathology (Zurich, Switzerland)
|
July 30, 2019
Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction
Yoshiki Hase, Tuomo M Polvikoski, Michael J Firbank, et al.
Food & Function
|
June 9, 2025
Correction: Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional decline
Mary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Nature Reviews. Neurology
|
April 24, 2020
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Nicholas J Ashton, Abdul Hye, Anto P Rajkumar, et al.
Food & Function
|
May 14, 2025
Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional decline
Mary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Geroscience
|
May 2, 2025
Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects
Miguel German Borda, Robinson Ramírez-Vélez, Felipe Botero-Rodriguez, et al.
JAMA Neurology
|
November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial
Robert Howard, Olga Zubko, Rosie Bradley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 5, 2025
Burden and care time for dementia caregivers in the LIVE@Home.Path trial
Line Iden Berge, Renira Corinne Angeles, Marie Hidle Gedde, et al.
Page
of 48
Search research articles
Search
Showing results (411-420 of 480) with videos related to
Sort By:
Page
of 48
International Journal of Geriatric Psychiatry
|
September 28, 2022
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.
Lancet (London, England)
|
September 25, 2025
Treatment for Alzheimer's disease
Nick C Fox, Christopher Belder, Clive Ballard, et al.
BMJ Open
|
March 1, 2022
PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trial
Jane L Cross, Simon P Hammond, Lee Shepstone, et al.
Brain Pathology (Zurich, Switzerland)
|
July 30, 2019
Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction
Yoshiki Hase, Tuomo M Polvikoski, Michael J Firbank, et al.
Food & Function
|
June 9, 2025
Correction: Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional decline
Mary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Nature Reviews. Neurology
|
April 24, 2020
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Nicholas J Ashton, Abdul Hye, Anto P Rajkumar, et al.
Food & Function
|
May 14, 2025
Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional decline
Mary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Geroscience
|
May 2, 2025
Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects
Miguel German Borda, Robinson Ramírez-Vélez, Felipe Botero-Rodriguez, et al.
JAMA Neurology
|
November 19, 2019
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial
Robert Howard, Olga Zubko, Rosie Bradley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 5, 2025
Burden and care time for dementia caregivers in the LIVE@Home.Path trial
Line Iden Berge, Renira Corinne Angeles, Marie Hidle Gedde, et al.
Page
of 48